Quadrature Capital LTD Novavax Inc Transaction History
Quadrature Capital LTD
- $5.81 Trillion
- Q2 2025
A detailed history of Quadrature Capital LTD transactions in Novavax Inc stock. As of the latest transaction made, Quadrature Capital LTD holds 30,321 shares of NVAX stock, worth $254,696. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,321Holding current value
$254,696% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVAX
# of Institutions
308Shares Held
94.2MCall Options Held
6.11MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$130 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$99.5 Million0.0% of portfolio
-
Shah Capital Management11.5MShares$96.7 Million35.13% of portfolio
-
State Street Corp Boston, MA6.82MShares$57.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.94MShares$33.1 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $657M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...